Dr. Piyush Kumar Agrawal - Best Surgical Oncology Doctor in India
Contact us Now
doctorprofile

Clinical Director & HOD - Surgical Oncology

Dr. Piyush Kumar Agrawal

Marengo Asia Hospital, Gurugram
  • Working At Marengo Asia Hospital, Gurugram
  • 20 Years of Experience

About Dr. Piyush Kumar Agrawal

  • Dr. Piyush Kumar Agrawal serves as the Clinical Director and Head of Department for Surgical Oncology at Marengo Asia Hospitals. With over 20 years of experience, he is a highly skilled and dedicated oncologist, known for his commitment to excellence in cancer treatment and patient care.
  • Throughout his extensive career, Dr. Agrawal has specialized in the latest advancements in surgical oncology, helping numerous patients overcome complex cancer diagnoses. His expertise and patient-centric approach have earned him a trusted reputation among both colleagues and patients.
  • Under his leadership, Marengo Asia Hospitals' oncology department has seen significant advancements, enhancing its capacity to deliver top-tier cancer care. Dr. Agrawal continues to drive innovation in oncology, ensuring each patient receives comprehensive, compassionate, and cutting-edge treatment.

Hospital

  • Marengo Asia Hospital, Gurugram

Locations

  • Gurugram. India

Special Interests

  • Robotic Surgery
  • HIPEC

List of Treatments

  • Minimally Invasive GI, Thoracic & Gynecological Cancer Surgeries
  • Head and Neck Cancers
  • Breast Cancer Surgeries, Breast Conservation Surgeries, Oncoplasty
  • Limb Preservation for Sarcomas
doctorprofile

Dr. Piyush Kumar Agrawal

Clinical Director & HOD - Surgical Oncology

Work Experience of Dr. Piyush Kumar Agrawal

  • Worked as Senior Consultant - Surgical Oncology in Sai Hospital and Gangasheel Hospital, Bareilly.
  • Worked as Senior Consultant - Surgical Oncology at Paras Hospitals, Gurgaon as team leader head and neck, breast, gynae, genitourinary oncology and sarcomas.
  • Worked as Senior Consultant - Surgical Oncology at Asian Institute of Medical Sciences, Faridabad looking after head & neck, gynae, thoracic, genitourinary oncology and sarcomas.